A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes

被引:14
作者
Mathur, P
Chaudhry, R [1 ]
Kumar, L
Kapil, A
Dhawan, B
机构
[1] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Med Oncol, New Delhi 110029, India
关键词
bacteremia; febrile neutropenia; hematological malignancies; anaerobes; antimicrobial resistance;
D O I
10.1385/MO:19:4:267
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients with hematological malignancies who are receiving chemotherapy suffer prolonged periods of neutropenia, which leads to a greater risk of infection and mortality. A prospective study was conduced to determine the incidence of bacteremia in patients of hematological malignancies over a 2-yr period. A total of 119 episodes of febrile neutropenia occurred among 96 consecutive patients, of which 35 episodes were associated with bacteremia. Forty-four percent of the isolated bacteria were Gram-positive aerobes and 46% were Gram-negative aerobes. Staphylococcus aureus, Enterococcus spp., and Escherichia coli were the most common isolates. Gram-negative bacteremia was associated with a higher mortality. Anaerobes accounted for 4.4% of all isolates. The episodes of anaerobic bacteremia were polymicrobial and had a fatal outcome. A high incidence of antimicrobial resistance among aerobic and anaerobic bacteria was also recorded. Compared to previous years, a shift from a predominating Gram-negative to a Gram-positive etiology was noted. The initial empiric antibiotic regimens should be based on a local knowledge of the most common causative microorganisms, their sensitivity pattern, and the outcome of bacteremia.
引用
收藏
页码:267 / 272
页数:6
相关论文
共 16 条
  • [1] AQUINO VM, 1995, PEDIATR INFECT DIS J, V14, P140
  • [2] Colle JG., 1996, Mackie McCarteny's Practical Medical Microbiology 14th Edition, P131
  • [3] Infections in neutropenic patients .1. Aetiology
    Engervall, P
    Bjorkholm, M
    [J]. MEDICAL ONCOLOGY, 1995, 12 (04): : 251 - 256
  • [4] Present status of therapy for anaerobic infections
    Finegold, SM
    Wexler, HM
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 : S9 - S14
  • [5] FORBES BA, 1998, BAILEY SCOTTS DIAGNO
  • [6] Freifeld Alison G., 1997, P2659
  • [7] GOLDSTEIN EJC, 1996, CLIN INFECT DIS S1, V23, P97
  • [8] JOHANSSON PJH, 1992, SCAND J INFECT DIS, V24, P357
  • [9] Kasthuri A S, 1990, J Assoc Physicians India, V38, P403
  • [10] Kumar L, 1992, J Assoc Physicians India, V40, P18